Centralisation of services for the management of ovarian cancer: Arguments against

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 10, 2007, Pages 1183-1187

  Crawford, S M ^a   Brunskill, P J ^a  

^a AIREDALE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRALIZATION; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; MEDICAL SPECIALIST; ONCOLOGY WARD; OVARY CANCER; PATIENT REFERRAL; POLICY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGEON;

EID: 34548692086     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01461.x     Document Type: Review

References (44)

1. Sant M, Aareleid T, Berrino F, et al. Eurocare-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003 14 (Suppl 5 v61 118.
2. Crawford SM. Cancer in the UK - a question of culture. Eur J Cancer 2000 36 : 1909 12.
3. Kitchener HC. Gynaecological cancer services: time for change. Br J Obstet Gynaecol 1997 104 : 123 6.
4. Expert Advisory Group on Cancer. A Policy Framework for Commissioning Cancer Services. Guidance for Purchasers and Providers of Cancer Services. London : Department of Health, 1995.
5. Improving Outcomes in Gynaecological Cancers - The Research Evidence. NHS Executive, 1999.
6. Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999 106 : 1130 6.
7. Crawford SM, Brunskill PJ. Guidelines for the management of ovarian cancer. BJOG 2000 107 : 1059 60.
8. Cancer Treatment Policies and Their Effects on Survival - Ovary. Key Sites Study 8. Leeds, UK : Northern and Yorkshire Cancer Registry and Information Service, 2002 http://www.nycris.org.uk Accessed 4 July 2007.
9. Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol 2002 87 : 260 7.
10. Tingulstad S, Skjldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003 101 : 885 91.
11. Nguyen H, Averette HE, Hoskins W, Penlaver M, Bernd-Uwe S, Steren A. National survey of ovarian carcinoma part V. The impact of physician's specialty on patients' survival. Cancer 1993 72 : 3663 70.
12. Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynaecologic oncologist and who is not? Gynecol Oncol 2002 84 : 36 42.
13. Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, et al. Ovarian cancer staging: does it require a gynaecologic oncologist? Gynecol Oncol 1992 47 : 223 7.
14. Kumpulainen S, Grenman S, Kyyronen P, Pukkala E, Sankila R. Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer 2002 102 : 541 4.
15. Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients Obstet Gynecol 2003 102 : 499 505.
16. Paulsen T, Kjærheim K, Kærn J, Tretli S, Tropé C. Improved short-term survival for advanced ovarian, tubal and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer 2006 16 : 11 17.
17. Kumpulainen S, Kuoppala T, Leminen A, Penttinen J, Puistola U, Pukkala E, et al. Surgical treatment of ovarian cancer in different hospital categories - a prospective nation-wide study in Finland. Eur J Cancer 2006 42 : 388 95.
18. Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, et al. Surgery by consultant gynaecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006 106 : 589 98.
19. Münstedt K, von Georgi R, Zygmunt M, Misselwitz B, Stillger R, Künzel W. Shortcomings and deficits in surgical treatment of gynaecological cancers: a German problem only? Gynecol Oncol 2002 86 : 337 43.
20. Münstedt K, von Georgi R, Misselwitz B, Zygmunt M, Stillger R, Künzel W. Centralizing surgery for gynaecologic oncology - a strategy assuring better quality treatment? Gynecol Oncol 2003 89 : 4 8.
21. Berman ML. Future directions in the surgical management of ovarian cancer. Gynecol Oncol 2003 90 : S33 9.
22. Berman ML. Reply to Letter to the Editor. Gynecol Oncol 2004 94 : 239 40.
23. Hoskins WJ, Blundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 1992 47 : 159 66.
24. Hunter RW, Alexander ND, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 1992 166 : 504 11.
25. Crawford SC, Vasey PA, Paul J, Hay A, Davis JA, Kaye SB. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial Abstract 5003, 2005 American Society of Clinical Oncology Annual Meeting Proceedings). J Clin Oncol 2005 23 : 455s.
26. Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004 40 : 1842 9.
27. Yawn B, Barratte BA, Wollan PC. Ovarian cancer: the neglected diagnosis. Mayo Clin Proc 2004 79 : 1277 82.
28. National Institute for Clinical Excellence. Clinical Guideline 27. Referral Guidelines for Suspected Cancer. London : NICE, 2005.
29. Scholz HS, Benedicic C, Haas J, Tamussino K, Petru E. Stage IV ovarian cancer: prognostic factors and survival beyond 5 years. Anticancer Res. 2001 21 : 3729 32.
30. Manual of Cancer Services Standards 2000. London : Department of Health. 2001.
31. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol 2003 21 : 1530 5.
32. Schrag D, Earle CC, Xu F, Panageas KS, Yabroff KR, Bristow RE, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst 2006 98 : 163 71.
33. A Policy Framework for Commissioning Cancer Services. Guidance for Purchasers and Providers of Cancer Services Department of Health, 1995.
34. Improving Outcomes in Gynaecological Cancers - The Research Evidence. NHS Executive, 1999.
35. Crawford SM, Brunskill PJ. Centralisation of services for the management of ovarian cancer: arguments against. BJOG 2007 114 : 1183 5.
36. Olaitan A, McCormack M. Centralisation of services for the management of ovarian cancer: arguments for. BJOG 2007 114 : 1188 90.
37. Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, et al. Ovarian cancer staging: does it require a gynaecologic oncologist? Gynecol Oncol 1992 47 : 223 7.
38. McGowan L, Lesher LP, Norris HJ, Barnett M. Misstaging of ovarian cancer. Obstet Gynecol 1987 65 : 568 72.
39. Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol 2003 102 : 499 505.
40. Covens AL. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 2000 78 : 269 74.
41. Giede KC, Kieser K, Dodge J, Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005 99 : 447 61.
42. Engleman MJA, Kos HE, Willemse PHB, Aalders JG, de Vries EG, Schaapveld M, et al. Surgery by consultant gynaecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 2006 106 : 589 98.
43. Kumpulainen S, Grenman S, Kyyronen P, Pukkala E, Sankila R. Evidence of benefit from centralized treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer 2002 102 : 541 4.
44. The future role of the consultant, a working party report. RCOG, 2005.